Solving all disease with AI
Isomorphic Labs (isomorphiclabs.com) scores 79 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Technology brands, SaaS brands, in the 64th percentile of 7752 Healthcare brands.
Isomorphic Labs is a British multinational artificial intelligence company founded in 2021 and headquartered in London. It is a subsidiary of Alphabet Inc., led by CEO Demis Hassabis. The company builds on the AlphaFold system to develop predictive and generative AI models aimed at accelerating drug discovery. Its mission is to advance human health by using AI to solve disease, targeting pharmaceutical and biotech partners, scientific researchers, and AI/ML talent.
| Brand Name | Isomorphic Labs |
|---|---|
| Domain | isomorphiclabs.com |
| Industry | Healthcare, Technology |
| Founded | 2021 |
| Headquarters | London |
| Parent Company / Owner | Alphabet Inc. |
| CEO | Demis Hassabis |
| Main Competitors | Recursion Pharmaceuticals (85/100), Insilico Medicine (83/100), Exscientia (80/100), BenevolentAI (74/100), Absci (81/100), XtalPi (77/100), Iambic Therapeutics (71/100) |
Moz Domain Authority 50/100 vs category average 40 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #287,387 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
Isomorphic Labs has a dedicated Wikipedia entity - a top-weighted signal AI models rely on to identify and describe the brand.
The homepage meta description reads "Isomorphic Labs is building a future where frontier AI can help to unlock deeper scientific insights, faster breakthroughs, and life-changing medicines." (Meta description: 21 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, og:description, og:image, og:type, Twitter cards. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: No robots.txt found (default: all bots allowed, but explicit file preferred) - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, Webflow.
Social footprint: verified profiles on LinkedIn, X (Twitter), Facebook, Instagram, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is Isomorphic Labs?", Claude could identify the brand as of September 2026. Isomorphic Labs is a London-based drug discovery company spun out of Alphabet/DeepMind by Demis Hassabis, using AI models (building on advances like AlphaFold) to computationally model biology and design new therapeutic drugs faster and more efficiently than traditional methods. Best known for Using DeepMind-derived AI (AlphaFold lineage) to accelerate drug discovery and design.
When asked "Best brands similar to Isomorphic Labs?", Claude would recommend Isomorphic Labs as of September 2026. It's one of the most prominent AI-driven drug discovery companies, backed by Alphabet and led by a Nobel laureate, making it a natural example in this space.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Isomorphic Labs's main competitors in Healthcare: Recursion Pharmaceuticals (85/100), Insilico Medicine (83/100), Exscientia (80/100), BenevolentAI (74/100), Absci (81/100).
Sources: Brand Analyzer scan
Isomorphic Labs is a British multinational artificial intelligence company founded in 2021 and headquartered in London. It is a subsidiary of Alphabet Inc. and is led by CEO Demis Hassabis. The company focuses on applying AI to drug discovery and human health.
Sources: Isomorphic Labs official site
Isomorphic Labs has moderate AI-search visibility, scoring 52/100 on Brand Analyzer's AI visibility composite (visibility 70, trust 29, recommendation 49). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Isomorphic Labs official site
Isomorphic Labs was founded in 2021. Isomorphic Labs operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Isomorphic Labs is headquartered in London. Isomorphic Labs operates in the Healthcare category.
Sources: Wikidata
Isomorphic Labs develops predictive and generative AI models, building on the Nobel-winning AlphaFold system, to accelerate scientific discovery in drug development. It combines drug discovery expertise with machine learning to help understand and treat diseases, working with pharmaceutical and biotech partners.
Sources: Isomorphic Labs official site
Isomorphic Labs scores 49/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: Isomorphic Labs official site
Isomorphic Labs offers predictive and generative AI models for drug discovery, building on the AlphaFold system, aimed at accelerating scientific research and identifying potential treatments for diseases.
Sources: Isomorphic Labs official site
Isomorphic Labs can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Isomorphic Labs official site
Isomorphic Labs is known for building on the Nobel-winning AlphaFold system to create AI models for drug discovery, and for being an Alphabet Inc. subsidiary led by Demis Hassabis, who also leads Google DeepMind.
Sources: Isomorphic Labs official site
Isomorphic Labs is owned by or part of Alphabet Inc.. Isomorphic Labs operates in the Healthcare category.
Sources: Wikidata
Isomorphic Labs' work is intended for pharmaceutical and biotech partners, scientific researchers, and AI/ML professionals interested in transforming drug discovery and advancing human health.
Sources: Isomorphic Labs official site
Isomorphic Labs scores 52/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Isomorphic Labs has a limited AI-visibility profile at 52/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is visibility (70/100) and its weakest is trust (29/100). It benefits from a recognised Wikipedia company entity, a Wikidata knowledge-graph entry and a global traffic rank of #287,387 (Tranco). The main gaps holding it back: thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Isomorphic Labs from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Isomorphic Labs: Ironwood Pharmaceuticals (79/100), Ionis Pharmaceuticals (79/100), Italfarmaco (79/100), iWorx (79/100).
A step up - brands to learn from: Zurich Insurance Group (81/100), ZOLL Data Systems (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.